Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -65.56%-13.2M | 18.28%-6.85M | 10.26%-7.97M | 18.65%-8.38M | -414.29%-8.89M | -177.86%-10.3M | -71.22%2.83M | -60.80%13.22M | -58.61%9.82M | -43.64%33.74M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 64.47%-81K | 20.47%-307K | -64.03%-228K | -324.18%-386K | -4,533.33%-139K | -193.55%-91K | 90.00%-3K | 91.73%-31K | 91.71%-30K | 46.73%-375K |
| Dividend (income)- adjustment | -8.33%-13K | ---- | 90.32%-12K | ---- | 0.00%-124K | ---- | ---124K | ---- | ---- | ---- |
| Impairment and provisions: | 531.41%985K | -81.10%31K | -75.00%156K | -72.25%164K | 18.63%624K | 210.88%591K | 265.28%526K | ---533K | -29.41%144K | ---- |
| -Other impairments and provisions | 531.41%985K | -81.10%31K | -75.00%156K | -72.25%164K | 18.63%624K | 210.88%591K | 265.28%526K | ---533K | -29.41%144K | ---- |
| Revaluation surplus: | -8.20%-66K | -176.15%-99K | -185.92%-61K | -61.19%130K | -56.97%71K | -54.48%335K | -81.08%165K | --736K | --872K | ---- |
| -Other fair value changes | -8.20%-66K | -176.15%-99K | -185.92%-61K | -61.19%130K | -56.97%71K | -54.48%335K | -81.08%165K | --736K | --872K | ---- |
| Asset sale loss (gain): | --1.1M | -129.27%-48K | ---- | -45.51%164K | -70.77%185K | -79.63%301K | 189.91%633K | 126.08%1.48M | 82.87%-704K | -2,176.31%-5.67M |
| -Loss (gain) on sale of property, machinery and equipment | --1.1M | -585.71%-48K | ---- | -118.42%-7K | -76.67%14K | -97.23%38K | 1,100.00%60K | 6,950.00%1.37M | 125.00%5K | 91.97%-20K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | -34.98%171K | -70.16%171K | 143.52%263K | 180.82%573K | 101.91%108K | 82.66%-709K | ---5.65M |
| Depreciation and amortization: | 7.96%3.61M | -12.53%6.49M | 37.36%3.34M | -26.55%7.42M | -46.14%2.43M | -3.07%10.1M | -17.65%4.52M | 4.71%10.42M | 26.12%5.49M | 52.08%9.96M |
| -Depreciation | 1.57%2.85M | -14.54%5.43M | 48.15%2.81M | -31.01%6.35M | -54.48%1.9M | -4.68%9.2M | -17.59%4.17M | 8.28%9.66M | 26.10%5.05M | 56.40%8.92M |
| Financial expense | 54.76%260K | 127.69%296K | 133.33%168K | 16.07%130K | 75.61%72K | 100.00%112K | 57.69%41K | -3.45%56K | -18.75%26K | -46.79%58K |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8,833.33%262K |
| Operating profit before the change of operating capital | -60.66%-7.4M | 36.12%-481K | 20.04%-4.61M | -171.31%-753K | -167.15%-5.76M | -95.83%1.06M | -45.04%8.58M | -33.22%25.35M | -34.51%15.62M | -42.37%37.97M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -421.75%-8.68M | -113.14%-1.64M | -119.52%-1.66M | 221.43%12.47M | 122.92%8.53M | 56.96%-10.27M | -86.88%-37.2M | -183.88%-23.86M | -203.63%-19.9M | 375.81%28.44M |
| Accounts payable increase (decrease) | 1,572.48%5.47M | 158.70%16.4M | 101.41%327K | -351.57%-27.94M | -368.95%-23.12M | 753.65%11.11M | -148.61%-4.93M | 104.70%1.3M | 149.34%10.15M | -231.98%-27.71M |
| prepayments (increase)decrease | 182.85%3.97M | 111.41%5.36M | 110.05%1.41M | -7.94%-46.98M | 76.09%-13.98M | -195.01%-43.52M | -512.13%-58.47M | 173.19%45.81M | 60.65%-9.55M | -34.10%-62.59M |
| Special items for working capital changes | ---- | -151.24%-23.98M | ---- | -8.11%46.8M | -70.62%20.99M | 150.87%50.92M | 509.66%71.47M | -844.03%-100.11M | 57.01%-17.45M | 52.27%-10.6M |
| Cash from business operations | -46.30%-6.64M | 73.54%-4.34M | 65.99%-4.54M | -276.43%-16.4M | 35.03%-13.35M | 118.06%9.3M | 2.79%-20.55M | -49.26%-51.5M | 50.10%-21.14M | -243.96%-34.5M |
| Hong Kong profits tax paid | ---- | -122.09%-728K | ---- | 136.26%3.3M | 82.18%-1.07M | -443.04%-9.09M | -4,133.10%-6.01M | 205.20%2.65M | 94.80%-142K | 86.05%-2.52M |
| Special items of business | 287.45%11.86M | ---- | ---6.33M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 148.00%5.22M | 61.33%-5.07M | 24.65%-10.87M | -6,312.80%-13.11M | 45.70%-14.42M | 100.43%211K | -24.81%-26.56M | -31.95%-48.85M | 52.81%-21.28M | -725.64%-37.02M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -64.47%81K | -20.47%307K | 64.03%228K | 324.18%386K | 4,533.33%139K | 193.55%91K | -90.00%3K | -91.73%31K | -91.71%30K | -46.73%375K |
| Dividend received - investment | 8.33%13K | ---- | -90.32%12K | ---- | 0.00%124K | ---- | --124K | ---- | ---- | ---- |
| Decrease in deposits (increase) | 6.33%-74K | 2.63%-148K | -17.91%-79K | -106.22%-152K | -102.68%-67K | 122,350.00%2.45M | --2.5M | -100.12%-2K | ---- | 139.32%1.67M |
| Sale of fixed assets | --791K | -15.79%48K | ---- | -44.66%57K | -62.50%27K | -97.58%103K | 3,500.00%72K | 21,165.00%4.25M | -90.00%2K | -91.97%20K |
| Purchase of fixed assets | -6.88%-6.31M | -81,333.33%-7.33M | ---5.9M | 99.82%-9K | ---- | -63.56%-4.9M | -21.68%-2.69M | 93.45%-3M | 86.87%-2.21M | -217.64%-45.78M |
| Recovery of cash from investments | ---- | ---- | ---- | -72.36%1.39M | -42.91%1.39M | -91.78%5.01M | -92.59%2.43M | -1.08%60.96M | 27.79%32.76M | --61.63M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 13.39%-58.06M | -39.29%-30.01M | ---67.03M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24.18M | ---- | ---- |
| Net cash from investment operations | 4.25%-5.5M | -527.23%-7.12M | -456.97%-5.74M | -39.32%1.67M | -33.83%1.61M | -90.32%2.75M | 329.33%2.43M | 157.75%28.37M | 104.80%566K | -177.51%-49.13M |
| Net cash before financing | 98.31%-280K | -6.55%-12.19M | -29.60%-16.61M | -486.82%-11.44M | 46.90%-12.81M | 114.44%2.96M | -16.49%-24.13M | 76.23%-20.48M | 63.58%-20.72M | -630.93%-86.15M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | -54.76%-260K | -127.69%-296K | -133.33%-168K | -16.07%-130K | -75.61%-72K | -100.00%-112K | -57.69%-41K | 3.45%-56K | 18.75%-26K | 46.79%-58K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.00%-10M |
| Net cash from financing operations | 27.79%-530K | 4.36%-1.38M | -1.52%-734K | -14.88%-1.44M | -52.85%-723K | -28.13%-1.26M | -2.38%-473K | 91.21%-981K | 95.56%-462K | -113.48%-11.16M |
| Net Cash | 95.33%-810K | -5.32%-13.57M | -28.10%-17.34M | -857.55%-12.89M | 44.98%-13.54M | 107.93%1.7M | -16.18%-24.6M | 77.95%-21.46M | 68.52%-21.18M | -237.04%-97.31M |
| Begining period cash | -32.11%28.69M | -23.37%42.26M | -23.37%42.26M | 3.18%55.15M | 3.18%55.15M | -28.65%53.45M | -28.65%53.45M | -56.50%74.91M | -56.50%74.91M | 70.16%172.21M |
| Cash at the end | 11.87%27.88M | -32.11%28.69M | -40.11%24.92M | -23.37%42.26M | 44.26%41.61M | 3.18%55.15M | -46.31%28.85M | -28.65%53.45M | -48.80%53.73M | -56.50%74.91M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | 33.80%33.35M | ---- | --24.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.